Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287516 · ClinicalTrials.gov registry record · NA
Validation of a Digital Visual Analogue Scale for Appetite Measurement
A NA study, sponsored by General Mills.
- Completed
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT05287516: Completed NA study, sponsored by General Mills.
NCT05287516 is a NA study that has completed, run by General Mills. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287516, a NA study, has completed, sponsored by General Mills.
- COMPLETED
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.
Primary Outcome
Area Under the Curve for Hunger 0-240 min
Interventions
- OTHER Breakfast meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2022-05-30 |
| Phase | NA |
What the finished NCT05287516 record still lists
NCT05287516 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Breakfast meal is the first listed.
NCT05287516 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05287516 about?
NCT05287516 is a clinical study titled "Validation of a Digital Visual Analogue Scale for Appetite Measurement". The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.
What is the current status of trial NCT05287516?
This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2022-04-01. Estimated completion is 2022-05-30.
What interventions are being tested in trial NCT05287516?
The interventions under investigation include: Breakfast meal (OTHER).
Who is sponsoring clinical trial NCT05287516?
This trial is sponsored by General Mills, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05287516's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI